Abstract
Vancomycin and its related glycopeptide antibiotics are known for their therapeutic importance against methicillin-resistant Staphylococcus aureus(MRSA). Unfortunately, vancomycin-resistant enterococci (VRE) have emerged as an important nosocomial pathogen worldwide, and recently vancomycin-resistant Staphylococcus aureus(VRSA) acquired the vanA-resistant gene from VRE.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Arimoto H, Nishimura K, Kinumi T, Hayakawa I, Uemura D (1999) Multivalent polymer of vancomycin: enhanced antibacterial activity against VRE. J Chem Soc Chem Commun 1999:1361–1362
Lu J, Yoshida O, Hayashi S, Arimoto H (2007) Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Chem Commun (Camb) 2007:251–253
Miura K, Yamashiro H, Uotani K, Kojima S, Yutsudo T, Lu J, Yoshida O, Yamano Y, Maki H, Arimoto H (2010) Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria. Antimicrob Agents Chemother 54:960–962
Nakama Y, Yoshida O, Yoda M, Araki K, Sawada Y, Nakamura J, Xu S, Miura K, Maki H, Arimoto H (2010) Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria. J Med Chem 53:2528–2533
Sundram UN, Griffin JH, Nicas TI (1996) Novel vancomycin dimers with activity against vancomycin-resistant enterococci. J Am Chem Soc 118:13107–13108
Griffin JH, Linsell MS, Nodwell MB, Chen QQ, Pace JL, Quast KL, Krause KM, Farrington L, Wu TX, Higgins DL, Jenkins TE, Christensen BG, Judice JK (2003) Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. J Am Chem Soc 125: 6517–6531
Yoshida O, Nakamura J, Yamashiro H, Miura K, Hayashi S, Umetsu K, Xu S, Maki H, Arimoto H (2011) New insight into the mode of action of vancomycin dimers in bacterial cell wall synthesis. Med Chem Commun 2:278–282
Rao JH, Whitesides GM (1997) Tight binding of a dimeric derivative of vancomycin with dimeric L-Lys-D-Ala-D-Ala. J Am Chem Soc 119:10286–10290
Jain RK, Trias J, Ellman JA (2003) D-Ala-D-Lac binding is not required for the high activity of vancomycin dimers against vancomycin. J Am Chem Soc 125:8740–8741
Acknowledgments
The author is grateful to collaborators in Tohoku University and Shionogi & Co., Ltd., whose names appear in the references, for their hard work, creativity, and superb research skills. This work was supported in part by Grants-in-Aid for Scientific Research from MEXT, Japan (Nos. 17035039, 18032010, and 21310136) and by funds from the Uehara Memorial Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer
About this paper
Cite this paper
Arimoto, H. (2012). Chemical Approaches for Understanding and Controlling Infectious Diseases. In: Shibasaki, M., Iino, M., Osada, H. (eds) Chembiomolecular Science. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54038-0_24
Download citation
DOI: https://doi.org/10.1007/978-4-431-54038-0_24
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54037-3
Online ISBN: 978-4-431-54038-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)